stockrow
Friday 6 November 2026
Export AHG’s income statement to Excel — free account
Akso Health Group Sponsored ADR
AHG Healthcare Medical Distribution
Akso Health Group Sponsored ADR’s revenue for fiscal 2026 (year ended March 2026) was $13.8 million, down 6.40% from fiscal 2025.
1.30
0.03
−2.26%
Follow AHG
Alert me
| Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 27.83 | 7.88 | 7.48 |
Piotroski F-Score |
5 | 4 | 4 | 4 | 4 | 3 | 2 | 1 | 7 | — |
Altman Z-Score |
112.75 | 10.01 | 9.49 | (4.45) | (0.58) | (2.75) | (0.84) | 3.59 | 16.66 | — |
P/S ratio |
1.84 | 0.95 | 0.92 | 0.30 | 3.43 | 2.56 | 1.32 | 2.65 | 4.79 | 0.00 |
Altman Z″-Score (non-manufacturers) |
23.59 | 10.58 | 44.96 | (9.73) | (1.48) | (5.32) | 0.93 | 7.04 | 16.39 | 14.00 |
P/FCF ratio |
0.00 | 1.42 | 0.00 | 0.00 | 0.68 | 0.68 | 0.49 | 1.78 | 4.81 | 6.16 |
P/Operating CF |
30.09 | (3.96) | 1.49 | 0.47 | 2.21 | 2.30 | 1.65 | 13.09 | 41.39 | 13.19 |
Beneish M-Score |
— | — | — | (4.58) | 3.88 | (9.62) | 3.62 | (2.33) | 0.33 | — |
P/B ratio |
0.19 | 0.10 | 3.48 | 0.67 | 2.24 | 1.66 | 0.20 | 1.29 | 3.67 | 4.99 |
Price to Tangible BV |
0.21 | 0.22 | 3.48 | 0.67 | 2.24 | 1.66 | 0.20 | 1.29 | 3.67 | 4.99 |
EV/Sales |
2.51 | (2.36) | 1.49 | 0.96 | 3.28 | 3.05 | 1.69 | 2.04 | 3.56 | 0.00 |
EV/EBITDA |
0.00 | 1.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.57 | 5.02 | 0.00 |
EV/Operating CF |
2.98 | (3.15) | (2.41) | (1.57) | 0.62 | 0.78 | 0.60 | 1.35 | 3.54 | 4.87 |
EV/FCF |
(0.32) | (3.52) | (2.12) | (1.37) | 0.65 | 0.81 | 0.62 | 1.37 | 3.57 | 4.94 |
Quick Ratio |
0.17 | 13.69 | 23.70 | 1.34 | 1.00 | 2.05 | 3.47 | 3.55 | 6.79 | 4.80 |
Current Ratio |
21.77 | 14.20 | 39.52 | 1.76 | 1.24 | 2.09 | 4.21 | 3.68 | 6.84 | 5.65 |
Net Debt/EBITDA |
(0.01) | 1.07 | 9.86 | 0.56 | 7.50 | 0.18 | (0.31) | (6.79) | (1.74) | (1.92) |
Debt/Assets |
0.18% | 0.00% | 0.00% | 0.00% | 0.00% | 31.56% | 25.77% | 11.54% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.58 | 0.43 | 0.16 | 0.00 | 0.00 |
Asset Turnover |
0.07 | 0.08 | 0.03 | 0.32 | 0.13 | 0.03 | 0.05 | 0.36 | 1.12 | 1.62 |
Operating CF/Net income |
0.69 | (0.01) | (0.14) | 2.39 | 0.51 | (0.29) | 0.82 | (0.31) | 1.34 | 0.96 |
Capex/Depreciation |
(74.07) | (0.07) | — | — | (0.27) | 0.00 | (1.60) | (2.31) | (2.61) | (3.12) |
Interest Coverage |
— | — | — | — | (3.05) | (13.34) | (18.25) | — | — | — |
| (9.83%) | (79.97%) | (12.85%) | (12.87%) | (114.02%) | (106.55%) | (81.55%) | 4.15% | 80.08% | 45.69% | |
| (9.23%) | (75.62%) | (11.64%) | (3.27%) | (35.67%) | (62.10%) | (56.12%) | 3.28% | 68.11% | 60.40% | |
ROIC |
(7.14%) | (453.47%) | (10.14%) | (974.52%) | 0.00% | (159.07%) | (48.36%) | 3.57% | 639.06% | 145.03% |
Return on Tangible Assets |
(10.32%) | (74.03%) | (6.83%) | (15.38%) | (136.55%) | (220.77%) | (179.12%) | 7.64% | 46.76% | 37.10% |
Average Days of Receivables |
33.81 | 318.51 | 0.00 | 213.13 | 1,954.37 | 2,992.82 | 1,912.89 | 220.04 | 99.54 | 66.60 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 31.03% | 14.93% | 12.06% | 7.92% | 22.47% |
Selling, General and Administrative Expense of Revenue |
28.84% | 24.64% | 362.85% | 117.86% | 51.03% | 1,616.05% | 322.50% | 79.63% | 21.34% | 34.28% |
Intangible Assets out of Total Assets |
0.00 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 6.53% | 3.16% | 5.03% | 10.74% | 1.71% | 0.00% |
Graham Net Nets |
0.13 | 4.58 | 0.29 | 1.58 | (0.59) | 1.17 | 0.24 | 0.31 | 0.27 | 0.20 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.95 | 30.24 | 0.00 |
Earnings Yield |
(7.89%) | (15.25%) | (15.79%) | (86.11%) | (58.58%) | (101.15%) | (119.07%) | 3.59% | 12.69% | 13.36% |
Free Cash Flow Yield |
(431.95%) | 70.34% | (76.47%) | (232.63%) | 147.45% | 146.74% | 204.97% | 56.15% | 20.78% | 16.22% |
Revenue per Share |
0.02 | 0.05 | 0.05 | 0.58 | 0.30 | 0.11 | 0.43 | 3.78 | 7.15 | 1.62 |
Operating CF per Share |
(0.02) | 0.00 | 0.03 | (0.14) | (0.43) | 0.62 | (3.59) | (0.11) | 5.85 | 0.58 |
Capex per Share |
(0.24) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.01) | (0.06) | (0.03) | (0.02) |
Free Cash Flow per Share |
(0.26) | 0.00 | 0.03 | (0.14) | (0.43) | 0.62 | (3.60) | (0.16) | 5.82 | 0.56 |
Cash per Share |
0.00 | 0.62 | 1.81 | 0.35 | 0.93 | 0.93 | 0.41 | 3.54 | 8.85 | 1.36 |
Shareholders Equity per Share |
0.25 | 0.70 | 2.93 | 0.39 | 0.62 | 1.06 | 2.96 | 7.79 | 9.34 | 1.67 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.25 | 0.70 | 2.93 | 0.39 | 0.62 | 1.06 | 2.96 | 7.79 | 9.34 | 1.67 |
Free Cash Flow |
(188.46) | 1.02 | 1.35 | (3.25) | (8.63) | 10.06 | (58.47) | (2.67) | 87.27 | 7.90 |
Working Capital |
180.84 | 182.31 | 138.42 | 8.84 | 12.29 | 15.71 | 39.66 | 71.12 | 139.28 | 22.68 |
Capital Expenditures |
(175.67) | (0.15) | — | — | 0.00 | — | (0.19) | (0.94) | (0.46) | (0.29) |
Net Current Asset Value |
180.84 | 180.32 | 138.42 | 8.84 | 12.29 | 15.71 | 19.64 | 50.93 | 139.28 | 22.68 |
EV/EBIT |
0.00 | 1.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.57 | 5.03 | 0.00 |
Capex to Sales |
12.70 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.00 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 31.90 | 6.77 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
197.63 | 133.53 | — | — | 0.33 | 0.23 | 1.30 | 0.32 | 0.23 | 0.22 |
Cash ROIC |
(103.87%) | 0.27% | 0.60% | (19.41%) | (28.11%) | 23.72% | (77.44%) | (1.31%) | 32.01% | 18.49% |
Accounts Receivable Turnover |
1.95 | 1.44 | 0.00 | 0.66 | 0.26 | 0.07 | 0.19 | 1.85 | 6.42 | 1.37 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Inventory Turnover |
70.94 | 78.97 | 2.44 | 2.51 | 0.00 | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Days of Inventory on Hand |
5.28 | 4.61 | 30.45 | 51.67 | 527.44 | — | — | — | — | — |
Average Receivables |
7.09 | 10.30 | — | 19.91 | 23.26 | 25.31 | 36.61 | 33.11 | 16.72 | 16.72 |
Average Inventory |
0.20 | 0.19 | 0.94 | 4.74 | — | — | — | — | — | — |
Average Assets |
202.29 | 178.49 | 81.24 | 41.63 | 47.25 | 56.08 | 126.87 | 168.57 | 96.14 | 14.19 |
Average Common Equity |
190.04 | 168.79 | 73.63 | 10.56 | 14.78 | 32.69 | 87.30 | 133.27 | 81.77 | 18.76 |
Columns are period end dates · fundamentals updated 26 Oct 2026